Quest PharmaTech Inc (QPT) — Cash Flow-to-Debt Ratio
Quest PharmaTech Inc (QPT) has a Cash Flow-to-Debt Ratio of -0.03x as of October 2025, meaning its operating cash flow of CA$-35.00K could theoretically repay 0% of its total liabilities (CA$1.25 Million) in one year. See cash generation quality of Quest PharmaTech Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quest PharmaTech Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Quest PharmaTech Inc across 13 annual periods. Also explore Quest PharmaTech Inc (QPT) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Quest PharmaTech Inc (1998–2025)
Year-by-year debt coverage analysis for Quest PharmaTech Inc. For market capitalisation and broader financial context, see how much is Quest PharmaTech Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.44x | CA$-511.88K | CA$1.17 Million | ▼ -69.2% |
| 2024 | -0.26x | CA$-342.42K | CA$1.32 Million | ▲ +48.4% |
| 2023 | -0.50x | CA$-554.68K | CA$1.11 Million | ▼ -82.8% |
| 2022 | -0.27x | CA$-170.78K | CA$622.60K | ▲ +95.8% |
| 2021 | -6.46x | CA$-2.52 Million | CA$389.44K | ▼ -2021.7% |
| 2020 | -0.30x | CA$-6.38 Million | CA$20.95 Million | ▲ +55.3% |
| 2019 | -0.68x | CA$-6.91 Million | CA$10.14 Million | ▲ +7.5% |
| 2018 | -0.74x | CA$-7.33 Million | CA$9.95 Million | ▲ +88.3% |
| 2017 | -6.28x | CA$-4.61 Million | CA$733.49K | ▼ -3169.4% |
| 2016 | -0.19x | CA$-2.56 Million | CA$13.30 Million | ▲ +59.8% |
| 2015 | -0.48x | CA$-1.94 Million | CA$4.07 Million | ▲ +19.2% |
| 2014 | -0.59x | CA$-1.96 Million | CA$3.31 Million | ▲ +97.5% |
| 1998 | -23.57x | CA$-81.77K | CA$3.47K | — |